InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Browse the full record of transactions filed by ROTE WILLIAM E., Dirigeant. Director active across 1 companies, notably Travere Therapeutics, Inc.. Aggregated, 11 reports have been published. Total volume traded: €148k. The latest transaction was filed on 11 May 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
€15,646750 shares@ €20.86090.0004% mcap10.6% of flow
Common Stock
SEC:0001209191-22-028710:0·
09,840 shares0
Common Stock
SEC:0001209191-22-006367·
09,840 shares0
Common Stock
SEC:0001209191-22-006367:0·
€41,2981,875 shares@ €22.02540.0010% mcap28.0% of flow
Common Stock
SEC:0001209191-22-005083:0·
€41,2981,875 shares@ €22.02540.0010% mcap62.6% of flow
Common Stock
SEC:0001209191-22-005083·
05,000 shares0
Common Stock
SEC:0001209191-22-003050·
05,000 shares0
Common Stock
SEC:0001209191-22-003050:0·
04,500 shares0
Common Stock
SEC:0001209191-21-052081·
04,500 shares0
Common Stock
SEC:0001209191-21-052081:0·
€24,6331,563 shares@ €15.76020.0006% mcap37.4% of flow
Common Stock
SEC:0001209191-21-032322·
€24,6331,563 shares@ €15.76020.0006% mcap16.7% of flow
Common Stock
SEC:0001209191-21-032322:0·
11 of 11 declarations
About ROTE WILLIAM E.
William E. Rote is the Senior Vice President of Research and Development at Travere Therapeutics, Inc. He is responsible for leading research initiatives aimed at developing innovative treatments for rare diseases. William E. Rote plays a key role in the company's product development strategy, ensuring that Travere Therapeutics, Inc. remains at the forefront of scientific advancements. His expertise in biopharmaceuticals is crucial for the success of research projects.
